Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
William Collis
AddedMar 31, 2024
UpdatedMay 31, 2026
William Collis

William Collis

Co-Founder, Adventris Pharmaceuticals

CrunchbaseLinkedInTwitter

William Collis's Career

Adventris Pharmaceuticals
Adventris Pharmaceuticals
Co-Founder
Adventris Pharmaceuticals
Adventris Pharmaceuticals

San Francisco, CA, US

Co-Founder
Team Genji
Team Genji

Concord, MA, US

Founder
Oxygen Esports
Oxygen Esports

Boston, MA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

William Collis's Career

Adventris Pharmaceuticals
Adventris Pharmaceuticals
Seed$500k72022
Co-Founder

Leadership at Adventris Pharmaceuticals

Mark YarchoanMark YarchoanCo-Founder
Jen HerbachJen HerbachCo-Founder

Similar to Adventris Pharmaceuticals

Adventris PharmaceuticalsAdventris PharmaceuticalsSan Francisco, CA, USCancer Vaccinesest. 2022Adventris PharmaceuticalsSan Francisco, CA, US · est. 2022

Adventris Pharmaceuticals, a San Francisco-based firm, specializes in developing cancer vaccines.

Pre-Seed · $500k6
Eris BiotechEris BiotechCancer Therapeuticsest. 2023Eris Biotechest. 2023

Developing HAPs to target solid tumors with reduced toxicity.

Seed · $500k2
Serinus BiosciencesSerinus BiosciencesNew York City, NY, USCancer Therapiesest. 2022Serinus BiosciencesNew York City, NY, US · est. 2022

Serinus Biosciences: AI-driven precision cancer therapy design to outsmart treatment resistance.

Pre-Seed · $500k6
Engage BioEngage BioSan Carlos, CA, USCancer Treatment, Immunotherapyest. 2021Engage BioSan Carlos, CA, US · est. 2021

Engage Bio: Pioneering mRNA treatments to target and eliminate cancer.

$3.9M
Adventris Pharmaceuticals
Adventris Pharmaceuticals
Pre-Seed$500k62022San Francisco, CA, US
Co-Founder

Leadership at Adventris Pharmaceuticals

Jen HerbachJen HerbachCo-Founder
Mark YarchoanMark YarchoanCo-Founder

Similar to Adventris Pharmaceuticals

Adventris PharmaceuticalsAdventris PharmaceuticalsCancer Vaccinesest. 2022Adventris Pharmaceuticalsest. 2022

Adventris develops cancer vaccines to prevent and treat cancer deaths.

Seed · $500k7
CancervaxCancervaxSanta Barbara, CA, USCancer Treatmentest. 2021CancervaxSanta Barbara, CA, US · est. 2021

CancerVAX Biotech: Santa Barbara-based medical firm innovating universal cancer treatments.

Seed · $500k13
Adjuvance TechnologiesAdjuvance TechnologiesLincoln, NE, USVaccine Adjuvantsest. 2009Adjuvance TechnologiesLincoln, NE, US · est. 2009

Adjuvance, a NY-based biopharmaceutical firm, innovates in vaccine adjuvant design and manufacturing.

Series A · $20M20
UbivacUbivacPortland, OR, USCancer Vaccinesest. 2005UbivacPortland, OR, US · est. 2005

UbiVac: A Portland-based biotech firm specializing in the development of therapeutic cancer vaccines.

Seed · $2.2M11
Team Genji
Team Genji
Seed$835k302018Concord, MA, US
Founder

Similar to Team Genji

Gen.GGen.GSeoul, Seoul, KREsports, Merchandiseest. 2017Gen.GSeoul, Seoul, KR · est. 2017

Gen.G: A top-tier global esports organization, headquartered in Santa Monica, Seoul, and Shanghai.

Series D · $46M114
Generation EsportsGeneration EsportsMissouri, USEsportsest. 2012Generation EsportsMissouri, US · est. 2012

Generation Esports: An innovative platform enabling esports competitions for schools, businesses, and communities.

Series C · $29.9M70
DignitasDignitasNewark, NJ, USEsports Teamsest. 2003DignitasNewark, NJ, US · est. 2003

Dignitas, a leading US-based esports organization, excels in League of Legends, Rocket League, and Fortnite.

Series A · $33.5M100
Oxygen Esports
Oxygen Esports
Series A$20M332020Boston, MA, US
Co-Founder

Leadership at Oxygen Esports

Jack VanderveldeJack VanderveldeCo-Founder
Murphy VanderveldeMurphy VanderveldeBoard Member
Adam MorrisonAdam MorrisonCo-Founder
Faraz BarmparFaraz BarmparCo-Founder

Similar to Oxygen Esports

Oath GamingOath GamingDes Plaines, IL, USEsports, Gamingest. 2019Oath GamingDes Plaines, IL, US · est. 2019

Oath Gaming: A global promoter and developer of professional esports.

Seed · $3.8M30
Slash 2 EsportsSlash 2 EsportsDetroit, MI, USEsports Dataest. 2018Slash 2 EsportsDetroit, MI, US · est. 2018

Comprehensive esports data tool for tracking team performance, managing player goals, and reporting to stakeholders.

Pre-Seed · $200k1
Esports OneEsports OneSanta Monica, CA, USFantasy Gamingest. 2017Esports OneSanta Monica, CA, US · est. 2017

Esports One leverages computer vision tech for real-time fantasy gaming and enhanced esports viewing.

Seed · $7.3M35

People Similar to William Collis

Achmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailKim Beom-sooKim Beom-sooCo-Founder · KakaoBrian KimBrian KimCo-Founder · KakaoJB LEEJB LEECo-Founder · Kakao